A Randomized Clinical Trial of Regdanvimab in High-Risk Patients With Mild-to-Moderate Coronavirus Disease 2019
Kim et al., Open Forum Infectious Diseases, doi:10.1093/ofid/ofac406
https://c19early.org/kim6.html